HOLDCO NUVO GROUP DG LTD (NUVO) Fundamental Analysis & Valuation

NASDAQ:NUVO • IL0012023656

Current stock price

0.17 USD
-0.05 (-23.56%)
At close:
0.2 USD
+0.03 (+17.65%)
After Hours:

This NUVO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. NUVO Profitability Analysis

1.1 Basic Checks

  • NUVO had negative earnings in the past year.
  • In the past year NUVO has reported a negative cash flow from operations.
NUVO Yearly Net Income VS EBIT VS OCF VS FCFNUVO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 2M -2M -4M -6M -8M

1.2 Ratios

  • NUVO's Return On Assets of -10.78% is in line compared to the rest of the industry. NUVO outperforms 59.26% of its industry peers.
  • NUVO has a Return On Equity (-25.68%) which is in line with its industry peers.
Industry RankSector Rank
ROA -10.78%
ROE -25.68%
ROIC N/A
ROA(3y)-3.34%
ROA(5y)N/A
ROE(3y)-8.29%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NUVO Yearly ROA, ROE, ROICNUVO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 -5 -10 -15 -20 -25

1.3 Margins

  • NUVO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NUVO Yearly Profit, Operating, Gross MarginsNUVO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. NUVO Health Analysis

2.1 Basic Checks

  • NUVO has less shares outstanding than it did 1 year ago.
  • There is no outstanding debt for NUVO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NUVO Yearly Shares OutstandingNUVO Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M 25M
NUVO Yearly Total Debt VS Total AssetsNUVO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

  • Based on the Altman-Z score of -1.73, we must say that NUVO is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -1.73, NUVO is not doing good in the industry: 62.96% of the companies in the same industry are doing better.
  • NUVO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.73
ROIC/WACCN/A
WACCN/A
NUVO Yearly LT Debt VS Equity VS FCFNUVO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • NUVO has a Current Ratio of 0.03. This is a bad value and indicates that NUVO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.03, NUVO is doing worse than 98.41% of the companies in the same industry.
  • A Quick Ratio of 0.03 indicates that NUVO may have some problems paying its short term obligations.
  • NUVO's Quick ratio of 0.03 is on the low side compared to the rest of the industry. NUVO is outperformed by 98.41% of its industry peers.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
NUVO Yearly Current Assets VS Current LiabilitesNUVO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M 4M 5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. NUVO Growth Analysis

3.1 Past

  • NUVO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -362.49%.
EPS 1Y (TTM)-362.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. NUVO Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NUVO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NUVO Price Earnings VS Forward Price EarningsNUVO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NUVO Per share dataNUVO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 0.3 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NUVO Dividend Analysis

5.1 Amount

  • NUVO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

NUVO Fundamentals: All Metrics, Ratios and Statistics

HOLDCO NUVO GROUP DG LTD

NASDAQ:NUVO (8/30/2024, 10:08:58 PM)

After market: 0.2 +0.03 (+17.65%)

0.17

-0.05 (-23.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.65M
Revenue(TTM)N/A
Net Income(TTM)-3.49M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.42
P/tB 0.42
EV/EBITDA N/A
EPS(TTM)-0.17
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.41
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.78%
ROE -25.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-3.34%
ROA(5y)N/A
ROE(3y)-8.29%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z -1.73
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-362.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-411.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-28.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.71%
OCF growth 3YN/A
OCF growth 5YN/A

HOLDCO NUVO GROUP DG LTD / NUVO Fundamental Analysis FAQ

What is the fundamental rating for NUVO stock?

ChartMill assigns a fundamental rating of 1 / 10 to NUVO.


Can you provide the valuation status for HOLDCO NUVO GROUP DG LTD?

ChartMill assigns a valuation rating of 0 / 10 to HOLDCO NUVO GROUP DG LTD (NUVO). This can be considered as Overvalued.


What is the profitability of NUVO stock?

HOLDCO NUVO GROUP DG LTD (NUVO) has a profitability rating of 1 / 10.


Can you provide the financial health for NUVO stock?

The financial health rating of HOLDCO NUVO GROUP DG LTD (NUVO) is 4 / 10.